NasdaqGS:ADUSHealthcare
What Does a Small Insider Sale Reveal About Addus HomeCare’s Regulatory Tailwind Story (ADUS)?
On May 19, 2026, Addus HomeCare director Esteban Lopez sold 250 shares of common stock in an open-market transaction at US$93.00 per share, leaving him with a remaining direct holding of roughly 3,200–3,450 shares disclosed in recent SEC Form 4 filings.
At the same time, analysts highlight that Addus HomeCare may benefit from regulatory pressure on self-directed operators and an aging U.S. population, potentially widening its opportunity to acquire client books and grow its home-care...